Operatsion marja: Qiagen (QGEN)

qiagen.com (QGEN) brendining ramzi va logotipi

Qiagen N.V. (QGEN) kompaniyasining molekulyar diagnostika sohasidagi global yetakchi sifatidagi begubor imidjini hisobga olgan holda, unga investitsiya kiritish maqsadga muvofiqmi? Kimyoviy moddalar ichki ishlab chiqarishda tayyorlanishi sababli, pudratchilarning me’yordagi ta’siri barqarorlikni tasdiqlaydi. EBIT orqali operatsion rentabellik tahlili xavfsizlik zaxirasini ochib beradi, bunda parametr 25.20 darajasida barqarorlashgan. Biznesning chidamliligi mijozlarni maxsus sarf materiallariga bog‘lab qo‘yuvchi "razor-blade" modeli bilan kafolatlangan.

qiagen.com (QGEN): Operatsion foyda bo'yicha sotuv rentabelligi 04.07.2022dan 20.11.2026gacha

Qiagen N.V. (QGEN) kompaniyasining tahliliy kesimlari

- aksiya narxi va baholash bo'yicha konsensus prognoz:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning asosiy tahlili:QGEN, Qiagen NV
Qiagen Corp asosiy tovari

Qiagen N.V. (QGEN) samaradorligini ob'ektiv baholash uchun menejerga foizlar va soliqlardan oldingi operatsion foyda marjasini tushunish juda muhimdir. EBIT marjasi tahlili biznesning asosiy operatsiyalardan pul oqimini yaratish qobiliyatini ochib beradi, bu esa Qiagen N.V. uchun o'rnatilgan analizatorlar bazasi uchun eksklyuziv sarf materiallarining yuqori marjalari bilan ta'minlanadi.

Qiagen N.V. (QGEN) raqobatchilari

Sotuvning operatsion marjasi TEM|Sotuvning operatsion marjasi Ionis Pharma (IONS)|Operatsion rentabellik Repligen Corp (RGEN)|RNA - Sotuvning operatsion rentabelligi|crisprtx.com - Sotuvning operatsion marjasi|Operatsion foyda normasi WGS|RARE - Operatsion rentabellik|Beam Tx (BEAM) - Sotuvning operatsion marjasi|SRPT (Sarepta Therapeutics Inc) - Sotuvning operatsion marjasi|TWST: Operatsion foyda koeffitsiyenti|TXG (10xgenomics.com) - Operatsion marja|NTLA (Intellia Therapeutics, Inc.) - Operatsion foyda koeffitsiyenti|Operatsion rentabellik Stoke Corp (STOK)|Operatsion faoliyat rentabelligi BioLife|Operatsion marja WVE (Wave Life Sciences Ltd)|MAZE: Operatsion foyda bo'yicha sotuv rentabelligi|Sionna Therapeutics, Inc. - Operatsion marja|Operatsion foyda normasi PRME (Prime Medicine Inc)|TSHA (Taysha Gene Therapies, Inc.) - Sotuvning operatsion marjasi|QURE - Operatsion faoliyat rentabelligi|MGTX (MeiraGTx Corp) - Operatsion marja|Sotuvning operatsion rentabelligi REGENXBIO Inc. RGNX|Operatsion rentabellik Solid Biosciences (SLDB)|Ocugen Corp - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion rentabellik Pacific Biosciences PACB|Operatsion foyda koeffitsiyenti BNTC (Benitec)|Design Corp - Operatsion marja|Rocket Pharmaceuticals - Operatsion foyda koeffitsiyenti|Operatsion foyda bo'yicha sotuv rentabelligi 4D Molecular Therapeutics, Inc.|Sotuvning operatsion rentabelligi Lexeo Therapeutics (LXEO)|KRRO (Korro Bio, Inc.) - Operatsion marja|Sotuvning operatsion rentabelligi Editas EDIT|Operatsion marja SLN|ProQR Therapeutics - Operatsion foyda bo'yicha sotuv rentabelligi|Operatsion marja CDXS (Codexis, Inc.)|SGMO: Operatsion foyda bo'yicha sotuv rentabelligi|Nautilus Biotechnology - Operatsion marja|Operatsion foyda normasi MGX (Metagenomi, Inc)|DTIL: Operatsion marja|GBIO: Operatsion foyda koeffitsiyenti|Operatsion rentabellik Boundless Bio Inc.|Sotuvning operatsion marjasi Exicure (XCUR)|Operatsion marja IMNN|PHIO (Phio Pharmaceuticals Corp.) - Operatsion foyda normasi|Mustang Bio, Inc. - Sotuvning operatsion marjasi|RNAZ - Sotuvning operatsion marjasi|BNGO: Sotuvning operatsion marjasi|APDN (Applied DNA Sciences Inc) - Operatsion foyda bo'yicha sotuv rentabelligi|BLUE (Bluebird Bio) - Sotuvning operatsion marjasi|ImmunoPrecise Antibodies Ltd - Operatsion foyda normasi|OMGA (Omega Therapeutics Inc) - Operatsion marja|Operatsion rentabellik OMIC|Operatsion rentabellik Regulus Therapeutics Inc. (RGLS)|Sotuvning operatsion marjasi Syros Pharmaceuticals, Inc. SYRS|Telesis Bio - Sotuvning operatsion marjasi|Operatsion foyda normasi TCON|UBX - Operatsion rentabellik